Literature DB >> 26592763

Assessment of Clostridium difficile Burden in Patients Over Time With First Episode Infection Following Fidaxomicin or Vancomycin.

Seth T Housman1, Abrar K Thabit1, Joseph L Kuti1, Richard Quintiliani2, David P Nicolau1.   

Abstract

In patients with first episode Clostridium difficile infection treated with vancomycin or fidaxomicin, more patients receiving fidaxomicin achieved at least 2 log10 colony-forming units/g reduction in spores at the follow-up visit (P=.02). Similar to published literature, a higher proportion of patients receiving fidaxomicin demonstrated sustained clinical response.

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26592763     DOI： 10.1017/ice.2015.270

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN： 0899-823X            Impact factor:   3.254


  8 in total

Review 1.  Comparison of three current Clostridioides difficile infection guidelines: IDSA/SHEA, ESCMID, and ACG guidelines.

Authors:  Abrar K Thabit; Mawadah H Alsolami; Nojoud A Baghlaf; Raghad M Alsharekh; Hadeel A Almazmumi; Afrah S Alselami; Fatmah A Alsubhi
Journal:  Infection       Date:  2019-08-19       Impact factor: 3.553

2.  Systematic Review with Meta-Analysis: Fecal Microbiota Transplantation for Severe or Fulminant Clostridioides difficile.

Authors:  Emily N Tixier; Elijah Verheyen; Yuying Luo; Lauren Tal Grinspan; Charles H Du; Ryan C Ungaro; Samantha Walsh; Ari M Grinspan
Journal:  Dig Dis Sci       Date:  2021-03-22       Impact factor: 3.199

3.  An exploratory study to evaluate Clostridium difficile polymerase chain reaction ribotypes and infection outcomes.

Authors:  Abrar K Thabit; David P Nicolau
Journal:  Infect Drug Resist       Date:  2016-06-27       Impact factor: 4.003

Review 4.  A Systematic Literature Review of Economic Evaluations of Antibiotic Treatments for Clostridium difficile Infection.

Authors:  Hannah E Burton; Stephen A Mitchell; Maureen Watt
Journal:  Pharmacoeconomics       Date:  2017-11       Impact factor: 4.981

Review 5.  Clostridium difficile infection in the elderly: an update on management.

Authors:  Tomefa E Asempa; David P Nicolau
Journal:  Clin Interv Aging       Date:  2017-10-24       Impact factor: 4.458

6.  Guideline for the Management of Clostridium Difficile Infection in Children and Adolescents With Cancer and Pediatric Hematopoietic Stem-Cell Transplantation Recipients.

Authors:  Caroline Diorio; Paula D Robinson; Roland A Ammann; Elio Castagnola; Kelley Erickson; Adam Esbenshade; Brian T Fisher; Gabrielle M Haeusler; Susan Kuczynski; Thomas Lehrnbecher; Robert Phillips; Sandra Cabral; L Lee Dupuis; Lillian Sung
Journal:  J Clin Oncol       Date:  2018-09-14       Impact factor: 44.544

Review 7.  Fidaxomicin vs Vancomycin for the Treatment of a First Episode of Clostridium Difficile Infection: A Meta-analysis and Systematic Review.

Authors:  Laith A Al Momani; Omar Abughanimeh; Boonphiphop Boonpheng; Joseph Gabriel Gabriel; Mark Young
Journal:  Cureus       Date:  2018-06-11

8.  A pilot study to assess bacterial and toxin reduction in patients with Clostridium difficile infection given fidaxomicin or vancomycin.

Authors:  Abrar K Thabit; M Jahangir Alam; Mohammed Khaleduzzaman; Kevin W Garey; David P Nicolau
Journal:  Ann Clin Microbiol Antimicrob       Date:  2016-04-12       Impact factor: 3.944
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.